Heritable disorders of the RANKL/OPG/RANK signaling pathway

Research output: Contribution to journalReview articlepeer-review

42 Scopus citations


Figure 7 summarizes the heritable disorders identified to date that directly involve the RANKL/OPG/RANK signaling pathway in humans. Activating mutations in TNFRSF11A encoding RANK and deactivating mutations in TNFRSF11B encoding OPG cause systemic bone disease (FEO, PDB2, ESH and JPD) featuring accelerated bone turnover, low bone mass, deafness early in life, and loss of dentition by enhancing signaling. No human disease has been identified involving defects in the TNFSF11 gene encoding RANKL. Despite genetic bases for these autosomal dominant and recessive conditions involving bone cell receptors, focal expansile osteolytic lesions are common and can occur perhaps from further local activation of osteoclast-mediated bone resorption following trauma. These disorders resemble PDB which can be inherited as an autosomal dominant trait with focal osteolytic disease, sometimes with deafness and tooth loss, and increasingly associated with mutations, but in other genes.

Original languageEnglish
Pages (from-to)254-267
Number of pages14
JournalJournal of Musculoskeletal Neuronal Interactions
Issue number3
StatePublished - Sep 2004


  • Alkaline phosphatase
  • Bisphosphonates
  • Bone resorption
  • Familial expansile osteolysis
  • Fracture
  • Hyperostosis
  • Hyperphosphatasia
  • Juvenile Paget disease
  • NF-B
  • Osteoclast
  • Osteolysis
  • Osteoprotegerin
  • Osteosarcoma
  • Paget bone disease
  • Skeletal remodelling
  • Tumor necrosis factor

Fingerprint Dive into the research topics of 'Heritable disorders of the RANKL/OPG/RANK signaling pathway'. Together they form a unique fingerprint.

Cite this